Safety of intramuscular COVID‐19 vaccination in patients with haemophilia

BACKGROUND: Guidelines recommend that patients with haemophilia should preferably receive vaccination subcutaneously. COVID‐19 and other vaccines, however, are only licenced for intramuscular application. AIMS: To assess the safety of intramuscular COVID‐19 vaccination in patients living with haemop...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiede, Andreas, Leise, Hendrik, Horneff, Silvia, Oldenburg, Johannes, Halimeh, Susan, Heller, Christine, Königs, Christoph, Holstein, Katharina, Pfrepper, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348084/
https://www.ncbi.nlm.nih.gov/pubmed/35561276
http://dx.doi.org/10.1111/hae.14586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348084/
https://www.ncbi.nlm.nih.gov/pubmed/35561276
http://dx.doi.org/10.1111/hae.14586

Ejemplares similares